abs197.txt	microbial	Î²-glucuronidases	(guss)	cause	severe	gut	toxicities	that	limit	theefficacy	of	cancer	drugs	and	other	therapeutics		selective	inhibitors	ofbacterial	gus	have	been	shown	to	alleviate	these	side	effects	using	structuraland	chemical	biology	mass	spectrometry	cell-based	assays	we	establish	thatpiperazine-containing	intercept	the	glycosyl-enzyme	catalyticintermediate	retaining	glycosyl	hydrolases	demonstrate	thatpiperazine-based	compounds	are	substrate-dependent	bind	tothe	gus-glca	catalytic	intermediate	as	a	piperazine-linked	glucuronide	(glca	glucuronic	acid)	confirm	gus-dependent	formation	inhibitor-glucuronideconjugates	by	lc-ms	show	methylated	piperazine	analogs	displaysignificantly	reduced	potencies	further	range	approvedpiperazine-	piperidine-containing	from	many	classes	including	thosefor	treatment	depression	infection	function	samemechanism	through	gene	editing	selectivelyinhibit	in	living	bacterial	cells	together	data	reveal	uniquemechanism	inhibition	may	impact	gusactivities	human
